Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer.
about
Involvement of Kallikrein-Related Peptidases in Normal and Pathologic ProcessesSoy and Health Update: Evaluation of the Clinical and Epidemiologic LiteratureDirect and indirect mechanisms of KLK4 inhibition revealed by structure and dynamics.Molecular pathways and targets in prostate cancerSTAMP2 increases oxidative stress and is critical for prostate cancer.Clinical significance of kallikrein-related peptidase-4 in oral cancerAnalysis of the interaction between Zinc finger protein 179 (Znf179) and promyelocytic leukemia zinc finger (Plzf).Targeting kallikrein-related peptidases in prostate cancer.Unleashing the therapeutic potential of human kallikrein-related serine proteases.Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challenges.mTOR and its tight regulation for iNKT cell development and effector function.KLK4 silencing inhibits the growth of oral squamous cell carcinoma through Wnt/β-catenin signaling pathway.Kallikrein-related peptidases (KLKs) and the hallmarks of cancer.Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.Delivery strategies and potential targets for siRNA in major cancer typesDivergent androgen regulation of unfolded protein response pathways drives prostate cancer.Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical ApplicationLong intergenic non-protein coding RNA 00858 functions as a competing endogenous RNA for miR-422a to facilitate the cell growth in non-small cell lung cancer.Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.Role of PLZF as a tumor suppressor in prostate cancer.Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition.PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2.Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer.The first potent diphenyl phosphonate KLK4 inhibitors with unexpected binding kinetics
P2860
Q26771266-07D074B5-99A2-4A41-85C5-AD416810076AQ28071946-1DAEE671-9C83-4D78-BCEC-562A6EE93320Q30825171-205EB0ED-FECD-46F5-8DDB-1E6394C45A87Q34365632-3E001290-02F9-4E6C-BD9C-36B0639EA623Q35192455-074BEDBB-1F6E-4F52-927C-CB5443F32C53Q36079284-205C68A7-08CF-4F2F-A9EC-2D4ECF21FA07Q37425770-4F3E34DF-26A6-4473-9BDD-720D0BE6CFD5Q38191293-9CE66F0F-C7D0-4D9C-8B8E-3FCB94CB77F6Q38362486-2A1E76D9-E489-49B8-9C4C-FD3E9ADD7EF6Q38413737-48174097-4E91-4910-BC21-D6CDE06E07A6Q38562587-66A13DAC-21D3-4A98-99DB-F6DEA80742A9Q38718409-B145E6F6-7014-42F3-841F-5AB2753393ADQ38737293-7D249316-5FAA-423F-870D-CE23E37647B0Q38760061-84EB5658-291B-4BF4-BED8-EC09CE69BD29Q38853191-A002CFA4-52F5-4AFE-80DA-19D0A1A6A115Q38888506-7FCAFD50-E7FF-4DA8-B927-E7D84AC5BE09Q38967490-4E24736B-0E1F-40AD-9125-334847B3FBD5Q42314770-EBFB4036-67CC-4635-A6A1-7859E870A50FQ42321600-61027C3D-D862-4406-8AAA-D11317F1BAB5Q42378532-66D8CCC0-1AA2-4BFF-A6A4-FAD1EDCC1872Q47998717-20F20E87-888B-4488-A37E-83351F7374EBQ49865189-3E58D9E9-33F7-4088-A2A2-4FD139E6F8EBQ55280710-0E0F7761-0182-44B7-A4B9-9E929EADD90FQ58864166-D0678F3F-73A8-4025-AEA1-0B7EDAA31D7C
P2860
Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular circuit involving KL ...... signaling in prostate cancer.
@en
Molecular circuit involving KL ...... signaling in prostate cancer.
@nl
type
label
Molecular circuit involving KL ...... signaling in prostate cancer.
@en
Molecular circuit involving KL ...... signaling in prostate cancer.
@nl
prefLabel
Molecular circuit involving KL ...... signaling in prostate cancer.
@en
Molecular circuit involving KL ...... signaling in prostate cancer.
@nl
P2093
P2860
P50
P356
P1476
Molecular circuit involving KL ...... R signaling in prostate cancer
@en
P2093
Alexandr Kristian
Anil K Sood
Bulent Ozpolat
Erkan Yuca
Gabriel Lopez-Berestein
Gunhild M Mælandsmo
Haiying Kong
Håvard E Danielsen
Ibrahim Tekedereli
P2860
P304
P356
10.1073/PNAS.1304318110
P407
P577
2013-06-24T00:00:00Z